September 24, 2005. The Food and Drug Administration (FDA) issued an “approvable letter” to Inamed Corporation for their silicone gel breast implants, and NCHR finds this unacceptable.
Read More »On Medical Treatments & Products
NCHR Statement on FDA Breast Implant Decision
July 28, 2005. The Food and Drug Administration (FDA) has issued an “approvable letter” to Mentor regarding their silicone gel breast implants. This does not mean that these implants have been approved, but it is a warning sign that corporate pressure on the FDA has once again put women’s health at risk.
Read More »NCHR Testimony at FDA on Hylaform
November 21, 2003. One concern about Hylaform is the lack of data for African Americans and Asian Americans. Only three of the patients are African American and only five are Asian American.
Read More »NCHR Testimony at FDA on Restylane
November 21, 2003. It is clear that both women and men alike continue to search for the fountain of youth. We know that these products are widely used, and that’s why they should be carefully studied. They should be approved if they are safe and effective.
Read More »Testimony at FDA on Silicone Gel Breast Implants
October 15, 2003. The FDA’s study, described by Dr. Lori Brown yesterday, is the best designed study ever conducted on the topic. One reason for its superiority is that it focused on women who were basically happy with their implants, and who had implants for at least 7 years.
Read More »